Genuine functions of P-glycoprotein (ABCB1)

被引:106
作者
Mizutani, Takaharu [1 ]
Masuda, Masatoshi [1 ]
Nakai, Emi [1 ]
Furumiya, Kenji [1 ]
Togawa, Hiroshi [1 ]
Nakamura, Yutaka [1 ]
Kawai, Yuko [1 ]
Nakahira, Keiko [1 ]
Shinkai, Shigeko [1 ]
Takahashi, Kazuhiko [1 ]
机构
[1] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan
关键词
P-glycoprotein; ABCB1; apoptosis; sphingomyelin; PAF; ceramide;
D O I
10.2174/138920008783571756
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoprotein (P-gp, ABCB1, MDR1) was recognized as a drug-exporting protein from cancer cells three decade ago. Apart from the multidrug transporter side effects of P-gp, normal physiological functions of P-gp have been reported. P-gp could be responsible for translocating platelet-activating factor (PAF) across the plasma membrane and PAF inhibited drug transport mediated by P-gp in cancer cells. P-gp regulated the translocation of sphingomyelin (SM) and GlcCer, and short chain C-6-NBD-GlcCer was found in the apical medium of P-gp cells exclusively and not in the basolateral membrane. SM plays an important role in the esterification of cholesterol. High expression of P-gp prevents stem-cell differentiation, leading to the proliferation and amplification of this cell repertoire, and functional P-gp plays a fundamental role in regulating programmed cell death, apoptosis. The transporter function of P-gp is therefore necessary to protect cells from death. P-gp can translocate both C-6-NBD-PC and C-6-NBD-PE across the apical membrane. This PC translocation was also confirmed with [H-3] choline radioactivity. Progesterone is not transported by P-gp, but blocks P-gp-mediated efflux of other drugs and P-gp can mediate the transport of a variety of steroids. Cells transfected with human P-gp esterified more cholesterol. P-gp might also be involved in the transport of cytokines, particularly IL-1 IL-2, IL-4 and IFN gamma, out of activated normal lymphocytes into the surrounding medium. P-gp expression is also associated with a volume-activated chloride channel, thus P-gp is bifunctional with both transport and channel regulators. We also present information about P-gp polymorphism and new structural concepts, "gate" and "twist", of the P-gp structure.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 71 条
[1]   P-glycoprotein kinetics measured in plasma membrane vesicles and living cells [J].
Aeaenismaa, Paeivi ;
Seelig, Anna .
BIOCHEMISTRY, 2007, 46 (11) :3394-3404
[2]   Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs [J].
Baker, EK ;
Johnstone, RW ;
Zalcberg, JR ;
El-Osta, A .
ONCOGENE, 2005, 24 (54) :8061-8075
[3]   Many P-glycoprotein substrates do not inhibit the transport process across cell membranes [J].
Barecki-Roach, M ;
Wang, EJ ;
Johnson, WW .
XENOBIOTICA, 2003, 33 (02) :131-140
[4]   Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells [J].
Barnes, KM ;
Dickstein, B ;
Cutler, GB ;
Fojo, T ;
Bates, SE .
BIOCHEMISTRY, 1996, 35 (15) :4820-4827
[5]   Restoration of TNF-α-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the p-glycoprotein blocker PSC833 [J].
Bezombes, C ;
Maestre, N ;
Laurent, G ;
Levade, T ;
Bettaïeb, A ;
Jaffrézou, JP .
FASEB JOURNAL, 1998, 12 (01) :101-109
[6]   Protein kinase C phosphorylation disengages human and mouse-1a P-glycoproteins from influencing the rate of activation of swelling-activated chloride currents [J].
Bond, TD ;
Valverde, MA ;
Higgins, CF .
JOURNAL OF PHYSIOLOGY-LONDON, 1998, 508 (02) :333-340
[7]  
BORST P, 2005, EMBO J, V24, P3159
[8]   Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein [J].
Bosch, I ;
DunussiJoannopoulos, K ;
Wu, RL ;
Furlong, ST ;
Croop, J .
BIOCHEMISTRY, 1997, 36 (19) :5685-5694
[9]   EXPRESSION AND ACTIVITY OF P-GLYCOPROTEIN, A MULTIDRUG EFFLUX PUMP, IN HUMAN HEMATOPOIETIC STEM-CELLS [J].
CHAUDHARY, PM ;
RONINSON, IB .
CELL, 1991, 66 (01) :85-94
[10]   DIVERSE MULTIDRUG-RESISTANCE-MODIFICATION AGENTS INHIBIT CYTOLYTIC ACTIVITY OF NATURAL-KILLER-CELLS [J].
CHONG, ASF ;
MARKHAM, PN ;
GEBEL, HM ;
BINES, SD ;
COON, JS .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (02) :133-139